Unknown

Dataset Information

0

A high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin.


ABSTRACT: Highly pathogenic avian influenza (HPAI) H5N1 virus infection is still a potential threat to public health worldwide. While vaccines and antiviral drugs are currently under development, neutralizing antibodies could offer an alternative strategy to prevent and treat H5N1 virus infection. In the present study, we had developed a humanized antibody against H5N1 viruses from mouse-derived hybridoma in order to minimize its immunogenicity for potential clinical application. The humanized antibody hH5M9 was generated by transferring the mouse complementarity determining region (CDR) residues together with four key framework region (FR) residues onto the FR of the human antibody. This humanized antibody exhibited high affinity and specificity comparable to the parental mouse or chimeric counterpart with broad and strong neutralization activity against all H5N1 clades and subclades except for Egypt clades investigated. Furthermore, through epitope mapping we identified a linear epitope on the top region of hemagglutinin (HA) that was H5N1 specific and conserved. Our results for the first time reported a humanized antibody against H5N1 viruses by CDR grafting method. With the expected lower immunogenicity, this humanized antibody was expected to be more efficacious than murine or human-mouse chimeric antibodies for future application in humans.

SUBMITTER: Xiong F 

PROVIDER: S-EPMC3928294 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

A high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin.

Xiong Feifei F   Xia Liliang L   Wang Jingfang J   Wu Biao B   Wang Dengyu D   Yuan Longfang L   Cheng Yating Y   Zhu Hongying H   Che Xiaoyan X   Zhang Qinghua Q   Zhao Guoping G   Wang Ying Y  

PloS one 20140218 2


Highly pathogenic avian influenza (HPAI) H5N1 virus infection is still a potential threat to public health worldwide. While vaccines and antiviral drugs are currently under development, neutralizing antibodies could offer an alternative strategy to prevent and treat H5N1 virus infection. In the present study, we had developed a humanized antibody against H5N1 viruses from mouse-derived hybridoma in order to minimize its immunogenicity for potential clinical application. The humanized antibody hH  ...[more]

Similar Datasets

| S-EPMC3302345 | biostudies-literature
| S-EPMC7682764 | biostudies-literature
| S-EPMC2916527 | biostudies-literature
| S-EPMC3838140 | biostudies-literature
| S-EPMC4054433 | biostudies-literature
| S-EPMC5315377 | biostudies-literature
| S-EPMC3995799 | biostudies-literature
| S-EPMC3571485 | biostudies-literature
| S-EPMC3187471 | biostudies-literature